On this page
Leptin deficiency
This condition causes profound, insatiable hunger from infancy, leading to rapid weight gain. It primarily affects children and can also impact endocrine function and immune responses, requiring lifelong management.
Overview
Leptin deficiency is a very rare inherited condition that causes severe obesity, typically starting in early childhood. Individuals with this condition experience extreme hunger, known as hyperphagia, which begins shortly after birth. This intense drive to eat leads to rapid weight gain and significant obesity from a young age [PMID:16037583]. The condition arises because the body cannot produce enough, or any, leptin, a hormone vital for signalling fullness to the brain and regulating energy balance.
Leptin plays a key role in controlling appetite, metabolism, and fat storage. Without sufficient leptin, the brain mistakenly believes the body is starving, leading to a constant urge to eat and a reduced rate of energy expenditure. This imbalance results in the accumulation of excess body fat. Beyond weight, leptin deficiency can also affect other bodily systems, including the endocrine and immune systems.
Symptoms & clinical features
The primary symptom of leptin deficiency is severe, early-onset obesity, often noticeable within the first few months of life. This is driven by profound and continuous hunger (hyperphagia), which can be very distressing for both the affected individual and their family. Infants may be irritable and constantly seek food, leading to rapid weight gain that surpasses typical growth charts [PMID:11590485].
Other symptoms can include delayed puberty or hypogonadotropic hypogonadism, a condition where the body does not produce enough sex hormones, affecting sexual development and fertility. Individuals may also experience problems with their immune system, leading to increased susceptibility to infections. Psychological impacts, such as behavioural challenges related to food, can also be present.
Video: Genetics 101
Affected organs
The main organs and systems affected by leptin deficiency are those involved in metabolism and hormone regulation. The brain, particularly the hypothalamus, is directly impacted as it does not receive the crucial satiety signals normally provided by leptin. This leads to dysregulation of appetite and energy expenditure.
Adipose tissue (body fat) is significantly increased due to the constant energy surplus. The endocrine system is also affected, with potential consequences for the reproductive organs (leading to delayed puberty or hypogonadism) and, in some cases, the thyroid and adrenal glands. The immune system may also be compromised, potentially increasing vulnerability to infections.
Risks & severity
Leptin deficiency typically presents with severe obesity from infancy, which, if untreated, can lead to significant health complications associated with extreme weight in childhood and adulthood. These include type 2 diabetes, high blood pressure, sleep apnoea, and joint problems. The severity of obesity can vary but is generally profound due to the persistent hyperphagia.
Undiagnosed and untreated leptin deficiency can have a significant impact on quality of life, mental health, and physical well-being. Early diagnosis and intervention are crucial to mitigate these long-term health risks and improve outcomes. The risk of developing associated health problems generally increases with age if the underlying leptin deficiency is not managed.
Genetic causes
Leptin deficiency is caused by pathogenic variants in the *LEP* gene. The *LEP* gene provides instructions for making leptin, a hormone primarily produced by fat cells (adipocytes). Leptin travels through the bloodstream to the brain, where it acts on specific receptors to signal that the body has enough energy stored as fat.
When there are pathogenic variants in the *LEP* gene, the body either produces a non-functional leptin protein or no leptin at all. This lack of functional leptin means the brain does not receive the signal of satiety, leading it to perceive the body as being in a state of starvation. Consequently, the brain triggers constant hunger and reduces energy expenditure, resulting in excessive food intake and severe obesity [PMID:16037583].
- LEP leptin
Inheritance pattern
Leptin deficiency is inherited in an autosomal recessive pattern. This means that an individual must inherit two copies of the altered *LEP* gene-one from each parent-to develop the condition. People who inherit only one altered copy of the *LEP* gene are called carriers. Carriers typically do not show symptoms of leptin deficiency because their one working copy of the gene is usually sufficient to produce enough functional leptin.
If both parents are carriers, there is a 25% chance with each pregnancy that their child will inherit two altered copies of the *LEP* gene and develop leptin deficiency. There is a 50% chance their child will be a carrier, and a 25% chance their child will inherit two normal copies of the gene and not be affected or a carrier.
When both parents are carriers, each child has a 25% chance of being affected, 50% of being a carrier, and 25% of being unaffected.
Diagnosis & testing
Diagnosis of leptin deficiency is typically suspected based on the clinical presentation of severe early-onset obesity and profound hyperphagia. Blood tests can measure leptin levels; very low or undetectable leptin levels in an individual with obesity strongly suggest leptin deficiency. However, confirming the diagnosis requires genetic testing.
Genetic testing involves analysing the *LEP* gene to identify specific pathogenic variants. This can be performed through gene sequencing. In the UK, genetic testing for severe early-onset obesity may be accessed via the NHS Genomic Medicine Service, often under specific R-codes related to syndromic or monogenic obesity. Referral to a clinical genetics service or a specialist paediatric endocrinology team is usually the pathway to obtaining such testing.
Management & lifestyle
Management of leptin deficiency primarily involves leptin replacement therapy, typically with a synthetic form of leptin. This treatment aims to replace the missing hormone, helping to regulate appetite, reduce hyperphagia, and promote weight loss. Clinical trials have shown significant improvements in body weight, body composition, and metabolic parameters with leptin replacement [PMID:11590485].
Beyond medication, a multidisciplinary approach is often beneficial, including dietary advice from a dietitian to support healthy eating patterns, psychological support for behavioural challenges related to food, and regular monitoring by an endocrinologist. Long-term follow-up is essential to monitor treatment effectiveness, manage associated health complications, and adjust care as needed. This integrated care is typically provided within the NHS by specialist teams.
UK care pathway
In the UK, individuals suspected of having leptin deficiency would typically be referred to specialist services, such as paediatric endocrinology or clinical genetics. These specialists can assess symptoms, arrange appropriate blood tests, and facilitate genetic testing through the NHS Genomic Medicine Service. The testing is guided by specific criteria and R-codes outlined in the National Genomic Test Directory, ensuring that eligible patients receive the most appropriate genomic investigations.
Following a diagnosis, ongoing care is provided by specialist teams, often involving endocrinologists, dietitians, and genetic counsellors. Genetic counsellors play a vital role in explaining the condition, its inheritance pattern, and the implications for the wider family.
Frequently asked questions
How rare is leptin deficiency?
Leptin deficiency is considered a very rare condition. The exact prevalence is not well established, but only a small number of cases have been identified worldwide, making it one of the less common causes of severe early-onset obesity.
Can leptin deficiency be treated?
Yes, leptin deficiency can be treated with leptin replacement therapy, which involves administering a synthetic form of leptin. This treatment helps to regulate appetite, reduce extreme hunger, and can lead to significant improvements in weight and metabolic health.
What is the typical age of onset for symptoms?
Symptoms of leptin deficiency typically begin very early in life, often within the first few months after birth. Parents usually notice profound, insatiable hunger and rapid weight gain in infancy.
If I have leptin deficiency, will my children have it?
Leptin deficiency is inherited in an autosomal recessive pattern. If you have the condition, it means you have two altered copies of the *LEP* gene. For your children to inherit the condition, they would also need to inherit an altered copy from your partner. If your partner is not a carrier, your children would be carriers but would not typically develop the condition.
Are there long-term health problems associated with leptin deficiency?
Without treatment, the severe obesity associated with leptin deficiency can lead to long-term health problems such as type 2 diabetes, high blood pressure, sleep apnoea, and joint issues. However, with appropriate leptin replacement therapy, many of these risks can be significantly reduced or prevented.
References
- Hu W, Zhu H, Gong F. Leptin and leptin resistance in obesity: current evidence, mechanisms and future directions. Endocrine connections. 2025. PMID: 40932169
- Ahima RS, Flier JS. Leptin: 30 Years Later. Annual review of physiology. 2026. PMID: 41043250
- Chaurasia B, Tippetts TS, Mayoral Monibas R. Targeting a ceramide double bond improves insulin resistance and hepatic steatosis. Science (New York, N.Y.). 2019. PMID: 31273070
- Cottrell EC, Mercer JG. Leptin receptors. Handbook of experimental pharmacology. 2012. PMID: 22249808
- Unger RH. Lipotoxic diseases. Annual review of medicine. 2002. PMID: 11818477
- von Schnurbein J, Zorn S, Nunziata A. Classification of Congenital Leptin Deficiency. The Journal of clinical endocrinology and metabolism. 2024. PMID: 38470203
- Zou T, Wan J, Liao R. Discovery of a carboxyl fullerene derivative as a new lipid droplet regulator inhibiting MASLD. Gut. 2026. PMID: 41309225
- Mao S, Fang L, Liu F. Leptin and chronic kidney diseases. Journal of receptor and signal transduction research. 2018. PMID: 29388492